Barzilai Medical Center is a 617-bed hospital in Ashkelon in southern Israel. The hospital serves a population of 500,000, including a large number of Ethiopian and Russian immigrants, and has more than 100,000 admissions annually.

During the past decade, Barzilai Medical Center; Neurology Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Barzilai Medical Center; Neurology Department" are "Idiopathic Pulmonary Fibrosis" (2 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "Barzilai Medical Center; Neurology Department" in a lesser frequency.

Most popular intervention types in "Barzilai Medical Center; Neurology Department" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Placebo" (2 trials) and "Ocrelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Barzilai Medical Center; Neurology Department" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Barzilai Medical Center; Neurology Department". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Barzilai Medical Center; Neurology Department, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Barzilai Medical Center; Neurology Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".